Body Composition Analyzers Market Report by Product, End User, and Region 2024-2032
체성분 분석기(BCA, Body Composition Analyzers) 시장 규모는 2023년 7억 7,520만 달러에 달했습니다. 앞으로 IMARC 그룹은 시장이 2032년까지 14억 7,130만 달러에 달할 것으로 예상했으며, 2024년과 2032년 사이에 7.2%의 성장률(CAGR)을 보일 것으로 예측했습니다.
체성분 분석기(BCA)는 체중, 체지방, 수분율, BMR, DCI, 대사 연령, 골량, 근육량, 체격 및 내장 지방률을 측정하는 장비입니다. BMI(체격 지수)보다 정확하게 체중을 정의하고 일정 기간의 누적 변동을 예측할 수도 있습니다. 현재 Ironman, FitScan 및 Innerscan을 포함한 광범위한 BCA 모델이 시장에 나와 있으며 의료 전문가에게 관련 측정 및 데이터를 제공하여 환자의 경과를 추적하고 비만 및 관련 병존 질환 진단 및 스크리닝에 유용합니다.
세계의 BCA 시장 성장을 뒷받침하는 주요 요인은 앉아있는 라이프 스타일과 건강에 해로운 식사 패턴으로 인한 비만 인구의 급증입니다. 비만률 및 기타 대사 이상이 증가함에 따라 건강과 웰빙의 중요성에 대한 개인의 의식이 높아지고 있습니다. 따라서 체중을 줄이기 위해 헬스 클럽과 피트니스 센터에 다니게 되었습니다. 이 센터는 BCA를 이용하여 정기적으로 개인의 신체 조성을 검사하기 때문에 산업 성장에 긍정적인 영향을 미칩니다. 또한, 시장 기업은 체지방률을 측정하기 위해 개업의가 사용하는 비침습적인 도구인 생체전기 임피던스 분석(BIA)을 개발하고 있습니다. 또한 듀얼 LCD 유닛을 갖춘 ANT 및 Bluetooth 무선 체성분 분석기도 개발되었습니다. 이와는 별도로 COVID-19의 세계의 확산이 계속되고 있기 때문에 각국 정부는 헬스케어 인프라의 정비에 투자하고 있어, 이것이 더욱 의료기기에 대한 큰 수요를 낳고 있습니다.
이 보고서에서 다루는 주요 질문
- 세계의 체성분 분석기 시장은 지금까지 어떻게 추이했으며, 향후 어떻게 추이할 것인가?
- 주요 지역 시장은?
- COVID-19가 세계의 체성분 분석기 시장에 미친 영향은?
- 제품별 시장 분석은?
- 최종 사용자별 시장 분석은?
- 산업 밸류체인의 다양한 단계란?
- 산업의 주요 촉진요인과 도전은 무엇인가?
- 세계의 체성분 분석기 시장의 구조와 주요 기업은?
- 산업 경쟁도는?
목차
제1장 서문
제2장 조사 범위 및 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 체성분 분석기 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 제품별
- 생체 임피던스 분석기
- 피하 지방 측정기
- 정수압 계량 장치
- 공기 변위 용적 맥파 기록법
- 듀얼 에너지 X선 흡수 측정법
- 기타
제7장 시장 내역 : 최종 사용자별
- 병원
- 피트니스 클럽과 웰니스 센터
- 학술연구센터
- 기타
제8장 시장 분석 : 지역별
- 북미
- 아시아 태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 남미
- 중동 및 아프리카
제9장 SWOT 분석
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 진입업자의 위협
- 대체품의 위협
제12장 가격 분석
제13장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- Bodystat Ltd.
- COSMED Srl
- GE Healthcare
- Hologic Inc.
- Inbody Co. Ltd.
- Omron Corporation
- RJL Systems Inc.
- Seca GmbH & Co. Kg.
- SELVAS Healthcare
- Tanita Corporation
LYJ
The global body composition analyzers market size reached US$ 775.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,471.3 Million by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.
A body composition analyzer (BCA) is an equipment that is used to measure weight, body fat, water percentage, BMR, DCI, metabolic age, bone mass, muscle mass, and physique and visceral fat rating. It defines weight more accurately than body mass index (BMI) and is also capable of projecting cumulative variations in the body for a certain amount of time. Nowadays, a wide range of BCA models, including Ironman, FitScan and Innerscan, are available in the market that provide relevant measurement values and data to medical professionals, which helps in tracking patient progress, and the diagnostics and screening of obesity and associated comorbidities.
The primary factor bolstering the growth of the global BCA market is the rapid growth of the obese population due to sedentary lifestyles and unhealthy dietary patterns. With the rising obesity rates and other metabolic disorders, there has been an increase in awareness among individuals about the importance of health and wellness. This has encouraged them to join health clubs and fitness centers to reduce weight. As these centers utilize BCA to test the body composition of individuals regularly, it is providing a positive impact on the industry growth. Moreover, market players have also developed Bio-electrical Impedance Analysis (BIA), which is a non-invasive tool used by medical practitioners to measure the percentage of body fat. They have also developed ANT+ and Bluetooth wireless body composition analyzers with dual LCD units. Apart from this, due to the ongoing spread of coronavirus disease (COVID-19) across the globe, governments of various nations are making investments in the development of healthcare infrastructure, which is further creating a huge demand for medical devices.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global body composition analyzers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and end user.
Breakup by Product:
Bioimpedance Analyzer
Skinfold Calipers
Hydrostatic Weighing Equipment
Air Displacement Plethysmography
Dual Energy X-Ray Absorptiometry
Others
Breakup by End User:
Hospitals
Fitness Clubs and Wellness Centers
Academic and Research Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Bodystat Ltd., COSMED Srl, GE Healthcare, Hologic Inc., Inbody Co. Ltd., Omron Corporation, RJL Systems Inc., Seca GmbH & Co. Kg., SELVAS Healthcare and Tanita Corporation.
Key Questions Answered in This Report:
- How has the global body composition analyzers market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global body composition analyzers market?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global body composition analyzers market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Body Composition Analyzers Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Bioimpedance Analyzer
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Skinfold Calipers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Hydrostatic Weighing Equipment
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Air Displacement Plethysmography
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Dual Energy X-Ray Absorptiometry
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by End User
- 7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Fitness Clubs and Wellness Centers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Academic and Research Centers
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.2 Asia Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Bodystat Ltd.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.2 COSMED Srl
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3 GE Healthcare
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 SWOT Analysis
- 13.3.4 Hologic Inc.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Inbody Co. Ltd.
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 Omron Corporation
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 RJL Systems Inc.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.8 Seca GmbH & Co. Kg.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.9 SELVAS Healthcare
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.10 Tanita Corporation
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
